Search

everythinglearnresearchcommunity

for

Search:↓

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Some chemotherapy can cause permanent hair loss.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Some cancer treatments can cause permanent hair loss.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.